Rising cost of state's drug habit

After the controversy over funding the cancer drug Ippy, the government is likely to come under pressure to pay for even more expensive treatments, writes Susan Mitchell.

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
5th May, 2012
A fair mechanism is needed for deciding which drugs are funded, says a consultant neurologist. Photo: Bloomberg

Anew drug to treat cystic fibrosis has recently been approved for use in the United States. Ivacaftor has been dubbed a wonder drug; officials from the US Federal Drugs Administration (FDA) hailed it as the first drug that targets an underlying cause of CF, rather than treating the symptoms of the disease.

It works by improving hydration of the airways, as well as the functioning of the lungs, and in clinical trials resulted in "significant...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago